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Ras inhibitors from a cell-permeable bicyclic peptide library
Many disease-relevant protein targets have been assessed as
undruggable as they are intracellular protein–protein interactions.
As such the targets are poorly addressed by small molecules that
lack the afﬁnity to bind to ﬂat, featureless protein surfaces, or by
biologics, such as antibodies, that could bind but have insufﬁcient
cell membrane permeability. A recent paper describes the use of
combinatorial chemistry to generate a library of bicyclic peptides
that contain a cell penetrating peptide sequence targeted against
the oncoprotein K-Ras G12V [1].
The authors have previously described a small cyclic peptide
that has powerful cell-penetrant properties. The cyclic peptide
contains the key sequence, FURRRR (in which U is L-2-naphthy-
lalanine), that is presumed to bind to phospholipids in the cell
membrane and results in internalisation by endocytosis. The pep-
tide also appears to be able to escape from the endosome to access
intracellular targets. It was anticipated that the delivery peptide
could be fused with other peptides to give a bicyclic peptide that
could deliver biologically active peptides to the cytosol. The onco-
protein K-Ras was selected as a target for a library of these bicyclic
peptides.
K-Ras is a GTPase that functions as a molecular switch during
cell signalling, but in cancer cells is frequently mutated, for exam-
ple at codon 12 (G12V), thereby making the protein constitutively
active resulting in unconstrained cell growth. Thus Ras is an onco-
protein that presents a compelling drug discovery target, but is
considered highly challenging because of the nature of the binding
surface and the intracellular location.
The library of bicyclic peptides comprised ﬁve variable residues
in one ring attached to a second ring containing the cell penetrant
peptide sequence outlined above. In fact two libraries were con-
structed; each containing the CPP sequence in different orienta-
tions. The variable residues comprised 26 amino acids, including
natural L-amino acids, some D-amino acids plus a range of more
diverse amino acids of unnatural origin. The overall library had a
theoretical diversity of 2.4  107 different sequences and was pre-
pared on TentaGel resin beads, with each bead displaying a unique
bicyclic peptide sequence, and a corresponding linear peptide
inside the bead that could be used subsequently as a decoding tag.http://dx.doi.org/10.1016/j.comche.2016.03.001
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The library was screened against biotinylated L-Ras G12V, and
active sequences identiﬁed by the subsequent recruitment of a
streptavidin–alkaline phosphatase conjugate to the bead surface,
and a colour change of the active beads. Manually separating
coloured beads and peptide sequencing by partial Edman degrada-
tion-mass spectrometry revealed the sequence of active binding
peptides.
Initial hits were measured to have afﬁnity in the micromolar
range, but further optimisation resulted in compounds such as 1
with a KDapp value of 0.21 lM. The compound was also tested for
its antiproliferative activity against H441 human lung cancer cells
where it reduced cell viability in a dose-dependent manner. The
peptide was also shown to be readily cell permeable and thus
demonstrates that combinatorial libraries can be used to ﬁnd cyclic
peptides active against an intracellular protein target.
A summary of the papers in this month’s issue
Polymer supported synthesis
No papers this month.
Solution-phase synthesis
A new and straightforward approach to synthesise benzo[b]
thiophene-fused imidazopyridines has been developed by tandem
14 N.K. Terrett / Combinatorial Chemistry - An Online Journal 18 (2016) 13–16cross-coupling reaction of K2S with 2-(2-bromophenyl)imidazo
[1,2-a]pyridines. In addition, the optical properties of a library of
benzo[b]thiophene-fused imidazopyridines were for the ﬁrst time
fully characterised. This synthetic strategy could also be applied
in the preparation of benzo[b]thiophene-fused indoles [2].
A facile, high yielding, and simple method for the synthesis of a
library of symmetrical biaryls by homocoupling of arenediazonium
salts has been reported, employing catalytic amounts of Pd(OAc)2
and the readily available imidazolium ionic liquids (ILs), without
oxidants, ligands, additives, or volatile solvents. Simple product
isolation and recycling/reuse of the IL represent additional advan-
tages of this method [3].
A mild and efﬁcient approach to the optically pure 6H-oxazolo
[3,2-f]pyrimidine-5,7-dione scaffold via the unexpected rearrange-
ment and ring contraction of 2,3-dihydropyrimido[6,1-b][1,5,3]-
dioxazepine-7,9(5H,8H)-diones derived from nucleoside
precursors has recently been reported. The procedure enables the
synthesis of a wide range of compounds with great structural
diversity. Compound structures were conﬁrmed by NMR spec-
troscopy and single crystal X-ray structural analysis, and the ﬁnal
products tested for cytotoxic effect on one non-cancerous (ﬁbrob-
lasts) and six cancer cell lines of different origins (colon, glioma,
breast, cervix, vulvar, and lung) [4].
Scaffolds and synthons for combinatorial libraries
As novel scaffolds with rigid inherent three-dimensional con-
formation, the bridged amino acid building blocks containing both
morpholine and pyrrolidine motifs, 2-oxa-5-azabicyclo[2.2.1]hep-
tane-4-carboxylic acid and 3-oxa-8-azabicyclo[3.2.1]octane-5-car-
boxylic acid, have been synthesised as compact modules for future
applications in the optimisation of drug candidates [5].
New non-ﬂattened amino group-containing building blocks and
ﬂuorinated analogues based on the spiro[3.3]heptane motif have
been synthesised as useful scaffolds. The syntheses included a
challenging deoxoﬂuorination of sterically hindered carbonyl
groups via an intermediate carbocation. The compounds thus pre-
pared could be useful in medicinal chemistry due to their three-
dimensional shape, and the varying pattern of ﬂuorine substitution
[6].
Solid-phase supported reagents
Two general methods for the C–N cross-coupling of phenyl-
boronic acids with amines using solid copper ﬂow reactors, in com-
bination with an oxidant have been described. One method has
been developed for a C–N arylation reaction which employs a solid
copper coil reactor, in combination with tert-butyl peroxyben-
zoate, to give products in moderate isolated yields. A general
method for the C–N cross coupling of phenylboronic acids using
a column packed with solid copper powder, in combination with
acetic acid and TEMPO, has also been developed to give products
in isolated yields in excess of 75+%. The general copper powder
method has been used to generate a library of products thus high-
lighting the utility of solid copper ﬂow reactors for C–N cross cou-
pling reactions, generating 16 examples in good yields [7].
Amino acid DL-threonine-derived ionic liquid has been treated
with salicylaldehyde to give the corresponding Schiff base which
subsequently was complexed with iron and used as a green cata-
lyst for aerobic oxidation of amines under solvent-less conditions.
The catalyst was readily synthesised, reusable, and exhibited supe-
rior catalytic activity owing to the synergistic effect of ionic liquid
moiety. Furthermore, the catalyst was found to be stable and could
be reused for several runs without any signiﬁcant loss in catalytic
activity [8].The synthesis of several polystyrene-supported BINOL (1,1-
binaphthol) ligands via radical polymerisation has been described.
These BINOL-based polymeric ligands were applied to the enan-
tioselective addition of triethylaluminium to aromatic aldehyde
in the presence of titanium isopropoxide. The products were
obtained with up to 93% enantiomeric excess in good to excellent
yield, and the ligands easily recovered and reused without losing
their catalytic activity or enantioselectivity [9].
Novel resins, linkers and techniques
The selective deprotection of Nx-nitro-arginine derivatives rep-
resents a major preparative challenge. This problem can be circum-
vented by the use of catalytic hydrogenation, but often high
pressure, elevated temperature, and/or long reaction times are
needed. For the ﬁrst time, the use of NaBH4 in the presence of a
metal ion catalyst to remove of the Nx-nitro moiety under simple,
‘open-vessel’ conditions has been described. This process using
NaBH4 does not remove the benzyloxycarbonyl-protecting group,
thus presenting an orthogonal method for this protecting scheme
[10].
Library applications
The marine natural product ()-8,15-diisocyano-11(20)-amphi-
lectene isolated from the Caribbean sponge Svenzea flava, has been
used as a scaffold to synthesise ﬁve new products, all of which
were tested against laboratory strains of Plasmodium falciparum
and Mycobacterium tuberculosis H37Rv. The scaffold contains two
isocyanide units that are amenable to chemical manipulation,
enabling them to be elaborated into a small library of sulphur
and selenium compounds. Although most of the analogues pre-
pared were less potent than the parent compound, one was nearly
equipotent showing IC50 values of 0.0066 lM and 0.0025 lM
respectively, against two strains (Dd2 and 3D7) of the malaria par-
asite [11].
1,4-Disubstituted-1,2,3-triazoles have been synthesised by Cu
(I) catalysed click chemistry, where the azides with electron donat-
ing and electron withdrawing groups acted as 1,3-dipoles and 1-
ethynyl-1-cyclohexanol served as the terminal alkyne. The product
triazoles were subjected to an enzymatic assay which showed
promising activity against a-glucosidase, and 1-(2-cyano-4-nitro-
phenyl)-4-(1-hydroxycyclohexyl)-1H-1,2,3-triazole being the most
active member of the library. Molecular docking studies of these
triazoles with the homology-modelled a-glucosidase protein were
also performed to delineate ligand–protein interactions at molecu-
lar level which suggested that Phe157, Arg312 and His279 are the
major interacting residues in the binding site of the protein and
may have a signiﬁcant role in the enzyme’s inhibition [12].
A novel library of 15 compounds, hydroxyamides and amides
containing a b-D-glucopyranose (D-Gluc) or a b-D-fructose (D-Fruc)
units has been designed, synthesised and screened for antiprolifer-
ative assays in breast (MCF-7) and colon (MDST8) cancer cell lines.
Twelve compounds were hydroxyamides and these were success-
fully synthesised from b-D-glucuronic acid (D-GluA). SAR studies
were conducted with these compounds, and antiproliferative stud-
ies showed that one compound potently inhibited the proliferation
of MDST8 cells [13].
The discovery of 2-amino-4-bis(aryloxybenzyl)aminobutanoic
acids as novel inhibitors of ASCT2(SLC1A5)-mediated glutamine
accumulation in mammalian cells has been reported. Focused
library development led to two novel ASCT2 inhibitors that exhibit
signiﬁcantly improved potency compared with prior art com-
pounds in C6 (rat) and HEK293 (human) cells. The potency of the
leads reported represents a 40-fold improvement over the most
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potent pharmacological inhibitors of ASCT2-mediated glutamine
accumulation in live cells. These and other compounds in this
novel series exhibit tractable chemical properties for further devel-
opment as potential therapeutic leads [14].
DNA display of PNA-encoded libraries was used to pair frag-
ments containing different phosphotyrosine surrogates with
diverse triazoles. Microarray-based screening of the combinatori-
ally paired fragment sets (62,500 combinations) against a proto-
typical phosphatase, PTP1B, was used to identify the ﬁttest
fragments. A focused library (10,000 members) covalently pairing
identiﬁed fragments with linkers of different length and geometry
was synthesised, and screening of the focused library against
PTP1B and closely related TCPTP revealed orthogonal inhibitors
with activity conﬁrmed by enzymatic inhibition assay [15].
The Polo Like family of protein kinases (PLKs) consists of ﬁve
members and of these, the role of PLK1 in human cancer is well
documented. PLK2 (SNK), which is highly homologous to PLK1,
has been shown to play a critical role in centriole duplication
and is also believed to play a regulatory role in the survival path-
way by physically stabilizing the TSC1/2 complex in tumour cells
under hypoxic conditions. A library of novel ATP mimetic chemo-
types that are cytotoxic against a panel of cancer cell lines has been
recently developed. One of these chemotypes, the 6-arylsulphonyl
pyridopyrimidinones, induces apoptosis of human tumor cell lines
at nanomolar concentrations, and the most potent of these com-
pounds, was found to be a highly speciﬁc inhibitor of PLK2 when
proﬁled against a panel of 288 wild type, 55 mutant and 12 lipid
kinases. The synthesis, structure activity relationship, in vitro
kinase speciﬁcity and biological activity of the lead compound,
has also been described [16].
A focused library of 34 new piperazinamides of 3-methyl- and
3,3-dimethyl-(2,5-dioxopyrrolidin-1-yl)propanoic or butanoic
acids has been prepared to reveal potential new hybrid anticonvul-
sants. These hybrid molecules join the chemical fragments of well-
known antiepileptic drugs (AEDs) such as ethosuximide, levetirac-
etam, and lacosamide. Initial anticonvulsant screening was per-
formed in mice (ip) using the ‘classical’ maximal electroshock
(MES) and subcutaneous pentylenetetrazole (scPTZ) tests as well
as in the six-Hertz model of pharmacoresistant limbic seizures.
The most favourable anticonvulsant properties were demonstrated
by one active compound that also displayed comparable or better
safety proﬁle than the clinically relevant AEDs, ethosuximide, laco-
samide or valproic acid [17].
2,3-Dihydrobenzofurans have been proposed as privileged
structures and used as a chemical platform to design small com-
pound libraries. By combining molecular docking calculations
and experimental veriﬁcation of biochemical interference, poten-
tial inhibitors of microsomal prostaglandin E2 synthase (mPGES)-
1 were selected. Starting from a low afﬁnity natural product, by a
combined approach several compounds with biological activity in
the low micromolar range were identiﬁed. 2,3-Dihydrobenzofuran
derivatives might be suitable bioinspired lead compounds for
development of new generation mPGES-1 inhibitors with
increased afﬁnity [18].
Treating bacterial infections can be difﬁcult due to innate or
acquired resistance mechanisms, and the formation of bioﬁlms.
Cyclic lipopeptides derived from fusaricidin/LI-F natural products
represent particularly attractive candidates for the development
of new antibacterial and antibioﬁlm agents, with the potential to
meet the challenge of bacterial resistance to antibiotics. A posi-
tional-scanning combinatorial approach has been used to identify
the amino acid residues responsible for driving antibacterial activ-
ity, and increase the potency of these cyclic lipopeptides. Screening
against the antibiotic resistant ESKAPE pathogens revealed the
importance of hydrophobic as well as positively charged aminoacid residues for activity of this class of peptides. The improvement
in potency was especially evident against bacterial bioﬁlms, since
the lead cyclic lipopeptide showed promising in vitro and in vivo
anti-bioﬁlm activity at a concentration far below its respective
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